Innovating Works

C.R.I.S

Desconocido
RD-MRI NETWORK: BRIDGING THE GAP BETWEEN ACADEMIA CLINICAL TRIALS FOR THE DEVELOPMENT OF RARE DISEASE TREATMENTS V... CONSULTANTS FOR RESEARCH IN IMAGING AND SPECTROSCOPY SCRL tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Rare diseases affect 36 million citizens in the EU with 75% of patients being children and 30% dying under the age of five. 94% of the 8,000...
2019-12-02 - 2020-05-31 | Financiado
BIOIMAGE-NMD: BIOIMAGE Neuromuscular Diseases CONSULTANTS FOR RESEARCH IN IMAGING AND SPECTROSCOPY SCRL participó en un FP7: BIOIMAGE-NMD will develop and apply imaging technology to monitor response to novel therapies in neuromuscular diseases (NMD) and will use D...
Financiado
SKIP-NMD: A phase I IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino... CONSULTANTS FOR RESEARCH IN IMAGING AND SPECTROSCOPY SCRL participó en un FP7: Duchenne muscular dystrophy (DMD) is a progressive, lethal muscle degenerative condition arising from the absence of dystrophin in skeletal...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.